{"id":360362,"date":"2025-08-30T14:06:44","date_gmt":"2025-08-30T14:06:44","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-castle-biosciences\/"},"modified":"2025-08-30T14:06:44","modified_gmt":"2025-08-30T14:06:44","slug":"how-to-buy-castle-biosciences","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/","title":{"rendered":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-360362","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Castle Biosciences (CSTL) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Castle Biosciences (CSTL) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin."},"intro":"Kanser tan\u0131s\u0131n\u0131n gelece\u011fine ait bir par\u00e7aya sahip oldu\u011funuzu hayal edin. Castle Biosciences, doktorlar\u0131n cilt kanserlerini tahmin etme ve tedavi etme \u015feklini ileri molek\u00fcler testlerle devrim niteli\u011finde de\u011fi\u015ftiriyor. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014hayat kurtaran ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeli olan bir teknolojiye yat\u0131r\u0131m yapma \u015fans\u0131.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kanser tan\u0131s\u0131n\u0131n gelece\u011fine ait bir par\u00e7aya sahip oldu\u011funuzu hayal edin. Castle Biosciences, doktorlar\u0131n cilt kanserlerini tahmin etme ve tedavi etme \u015feklini ileri molek\u00fcler testlerle devrim niteli\u011finde de\u011fi\u015ftiriyor. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014hayat kurtaran ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeli olan bir teknolojiye yat\u0131r\u0131m yapma \u015fans\u0131."},"body_html":"<h2>\ud83d\udcc8 Castle Biosciences Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla, Castle Biosciences (CSTL) hisseleri <strong>21,35 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor ve hassas t\u0131p devrimine g\u00f6z diken yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir giri\u015f noktas\u0131 sunuyor.<\/p> <p><strong>Takviminize not edin: 3 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck f\u0131rsat\u0131n\u0131z. Castle Biosciences, piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketlerine neden olur\u2014hem yukar\u0131 hem de a\u015fa\u011f\u0131 y\u00f6nl\u00fc.<\/p> <h3>Kazan\u00e7 Etkisi Analizi: Haberler CSTL Hissesini Nas\u0131l Hareket Ettiriyor<\/h3> <p>Bu \u015firketin finansal haberlere nas\u0131l tepki verdi\u011fini g\u00f6stereyim. \u0130\u015fte son kazan\u00e7lardan sonra olanlar:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>4 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>19,90 $<\/td><td><strong>%8,2 Art\u0131\u015f<\/strong> (tahminleri a\u015ft\u0131)<\/td><\/tr> <tr><td>5 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>22,50 $<\/td><td><strong>%4,0 Art\u0131\u015f<\/strong> (gelir art\u0131\u015f\u0131)<\/td><\/tr> <tr><td>\u015eub 2025<\/td><td>Ayl\u0131k Kapan\u0131\u015f<\/td><td>27,05 $<\/td><td><strong>%-0,53 D\u00fc\u015f\u00fc\u015f<\/strong> (stabil d\u00f6nem)<\/td><\/tr> <tr><td>Oca 2025<\/td><td>Volatilite Art\u0131\u015f\u0131<\/td><td>23,95 $<\/td><td><strong>%6,08 Art\u0131\u015f<\/strong> (toparlanma)<\/td><\/tr> <\/tbody> <\/table> <p>Desen a\u00e7\u0131k: Castle Biosciences genellikle olumlu kazan\u00e7 s\u00fcrprizlerine iyi tepki veriyor. 4 A\u011fustos raporu beklentileri ezerek %8,2\u2019lik bir s\u0131\u00e7rama yaratt\u0131. Bu volatilite, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem risk hem de f\u0131rsat yarat\u0131yor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>Castle Biosciences, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131. Hikaye \u015f\u00f6yle geli\u015fti:<\/p> <p><strong>\u015eubat 2025<\/strong>: 27,05-28,90 $ aras\u0131nda i\u015flem g\u00f6r\u00fcrken, hisse % -0,53 gibi minimal bir hareketle istikrar g\u00f6sterdi. Yat\u0131r\u0131mc\u0131lar temkinli iyimserdi.<\/p> <p><strong>Mart-Nisan 2025<\/strong>: Hisse, piyasa \u015firketin b\u00fcy\u00fcme yol haritas\u0131n\u0131 de\u011ferlendirirken yakla\u015f\u0131k 24 $ destek seviyelerini test ederek konsolidasyon a\u015famas\u0131na girdi.<\/p> <p><strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek kazan\u00e7lar\u0131 yenilenmi\u015f ilgi uyand\u0131rd\u0131 ve fiyatlar\u0131 23-25 $ aral\u0131\u011f\u0131na ta\u015f\u0131d\u0131; y\u0131ll\u0131k %21 olumlu gelir art\u0131\u015f\u0131 g\u00f6r\u00fcld\u00fc.<\/p> <p><strong>Haziran-Temmuz 2025<\/strong>: Atopik dermatit testleri i\u00e7in SciBase i\u015f birli\u011fi duyurusu heyecan yaratt\u0131, ancak geri \u00f6deme endi\u015feleri ge\u00e7ici olarak co\u015fkuyu azaltt\u0131.<\/p> <p><strong>A\u011fustos 2025<\/strong>: \u015eu anki 21,35 $ civar\u0131ndaki i\u015flem fiyat\u0131, bir\u00e7ok analistin son bask\u0131lar sonras\u0131 potansiyel bir de\u011fer f\u0131rsat\u0131 olarak g\u00f6rd\u00fc\u011f\u00fc seviyeyi temsil ediyor.<\/p> <p>Genel trend? <strong>\u015eubat zirvelerinden %17 d\u00fc\u015f\u00fc\u015f<\/strong>, ancak g\u00fc\u00e7l\u00fc temel performans bunun uzun vadeli bir d\u00fc\u015f\u00fc\u015ften ziyade ge\u00e7ici bir gerileme olabilece\u011fini g\u00f6steriyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket performans\u0131na dayanarak, gelecekte neler olabilir:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 26-28 $ (y\u00fczde 22-31 art\u0131\u015f) \u2192 <strong>AL<\/strong><br> G\u00fc\u00e7l\u00fc 3. ve 4. \u00e7eyrek performans\u0131 bekleniyor, gelir rehberi zaten 310-320 milyon $ olarak y\u00fckseltildi<\/li> <li><strong>2026<\/strong>: 32-35 $ (y\u00fczde 50-64 b\u00fcy\u00fcme)<br> Yeni dermatolojik testlerin geni\u015flemesi ve potansiyel FDA onaylar\u0131 b\u00fcy\u00fcmeyi tetikliyor<\/li> <li><strong>2028<\/strong>: 40-45 $ (y\u00fczde 87-111 de\u011fer art\u0131\u015f\u0131)<br> Hassas dermatoloji tan\u0131 pazar\u0131nda liderlik kurulacak<\/li> <li><strong>2030<\/strong>: 50 $+ (y\u00fczde 134+ potansiyel)<br> Geni\u015fletilmi\u015f test portf\u00f6y\u00fc ile molek\u00fcler tan\u0131 alan\u0131nda hakimiyet<\/li> <\/ul> <p>Ortalama hedef fiyat\u0131 37,67 $ olan analistlerin oybirli\u011fiyle verdikleri <strong>G\u00fc\u00e7l\u00fc Al tavsiyesi<\/strong>, bu b\u00fcy\u00fcme yolunda \u00f6nemli bir g\u00fcveni g\u00f6steriyor.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2> <p>Yat\u0131r\u0131m yapmadan \u00f6nce bu potansiyel riskleri anlay\u0131n:<\/p> <ul> <li><strong>Reg\u00fclasyon Riskleri<\/strong>: FDA onay s\u00fcre\u00e7leri yeni \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir. DecisionDx-SCC i\u00e7in Medicare geri \u00f6deme sorunlar\u0131, politika de\u011fi\u015fikliklerinin marjlar\u0131 nas\u0131l etkileyebilece\u011fini g\u00f6steriyor.<\/li> <li><strong>Mali Volatilite<\/strong>: G\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131na ra\u011fmen (-9,47M $ TTM zarar), k\u00e2rl\u0131l\u0131k \u00f6l\u00e7ek b\u00fcy\u00fcmesi sa\u011flanana kadar endi\u015fe kayna\u011f\u0131d\u0131r.<\/li> <li><strong>Rekabetin Artmas\u0131<\/strong>: Daha b\u00fcy\u00fck tan\u0131 \u015firketleri, Castle\u2019\u0131n ni\u015f pazarlar\u0131na rakip teknolojilerle girebilir.<\/li> <li><strong>\u0130\u00e7erden Sat\u0131\u015flar<\/strong>: Son d\u00f6nemdeki y\u00f6netici hisse sat\u0131\u015flar\u0131, muhtemelen planl\u0131 olsa da, bireysel yat\u0131r\u0131mc\u0131lar aras\u0131nda olumsuz alg\u0131 yaratabilir.<\/li> <\/ul> <h2>\ud83d\udea6 Olumlu Sinyaller: Neden Analistler \u0130yimser?<\/h2> <p>\u0130yi haberler \u015fimdi\u2014ak\u0131ll\u0131 paran\u0131n heyecanlanmas\u0131n\u0131n nedenleri:<\/p> <ul> <li><strong>Gelir B\u00fcy\u00fcme Motoru<\/strong>: 2025 1. \u00e7eyre\u011finde %21 y\u0131ll\u0131k b\u00fcy\u00fcme ile 88 milyon $ gelir, g\u00fc\u00e7l\u00fc ticari uygulamay\u0131 g\u00f6steriyor.<\/li> <li><strong>\u0130novasyon Hatt\u0131<\/strong>: Atopik dermatit testleri i\u00e7in SciBase i\u015f birli\u011fi, ABD\u2019de 24 milyon hastay\u0131 hedefleyen devasa bir adreslenebilir pazar.<\/li> <li><strong>Pazar Liderli\u011fi<\/strong>: 2008\u2019den beri 300.000\u2019den fazla test raporu sunulmas\u0131, klinik g\u00fcvenilirlik ve doktor ili\u015fkileri kurdu.<\/li> <li><strong>Nakit Pozisyonu<\/strong>: 275,9 milyon $ nakit rezervi, seyrelme olmadan sat\u0131n almalar ve Ar-Ge i\u00e7in finansman sa\u011fl\u0131yor.<\/li> <\/ul> <h2>\ud83d\udcca \u00d6nemli Haber Analizi: 2025 Geli\u015fmeleri<\/h2> <p>Son alt\u0131 ayda her CSTL yat\u0131r\u0131mc\u0131s\u0131n\u0131n anlamas\u0131 gereken kritik geli\u015fmeler:<\/p> <ul> <li><strong>2. \u00c7eyrek Kazan\u00e7 S\u00fcrprizi (4 A\u011fustos)<\/strong>: Castle, -0,51 $ tahminine kar\u015f\u0131 0,15 $ EPS ile beklentileri ezdi. 86,18 milyon $ gelir tahminleri %20 a\u015ft\u0131. Bu, zorluklara ra\u011fmen operasyonel m\u00fckemmelli\u011fi g\u00f6steriyor.<\/li> <li><strong>SciBase \u0130\u015f Birli\u011fi (Haziran 2025)<\/strong>: Atopik dermatit testleri geli\u015ftirmek i\u00e7in bu ortakl\u0131k d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc olabilir. Sadece ABD\u2019de 24 milyon potansiyel hasta ile b\u00fcy\u00fck bir kar\u015f\u0131lanmam\u0131\u015f ihtiyaca hitap ediyor.<\/li> <li><strong>FDA At\u0131l\u0131m Tasar\u0131m\u0131<\/strong>: DecisionDx-Melanoma\u2019n\u0131n bu stat\u00fcy\u00fc almas\u0131, teknolojinin potansiyelini do\u011fruluyor ve tam onay yolunu kolayla\u015ft\u0131r\u0131yor.<\/li> <li><strong>Geri \u00d6deme Zorluklar\u0131<\/strong>: Medicare politika de\u011fi\u015fiklikleri br\u00fct marj\u0131 %80,7\u2019den %77,3\u2019e d\u00fc\u015f\u00fcrd\u00fc, ancak y\u00f6netim bunu yeniden de\u011ferlendirme talepleriyle aktif olarak ele al\u0131yor.<\/li> <\/ul> <h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2> <p>Analizime dayanarak, \u00f6nerilerim \u015funlar:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5\u2019inden fazlas\u0131n\u0131 ba\u015flang\u0131\u00e7ta CSTL\u2019ye ay\u0131rmay\u0131n\u2014bu y\u00fcksek b\u00fcy\u00fcme ve y\u00fcksek riskli bir yat\u0131r\u0131m.<\/li> <li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferde b\u00fcy\u00fck al\u0131m yerine, \u00f6n\u00fcm\u00fczdeki 2-3 ay i\u00e7inde taksitlerle almay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li> <li><strong>3 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: Kazan\u00e7 tarihini i\u015faretleyin ve rapor sonras\u0131 olas\u0131 d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 haz\u0131r olun.<\/li> <li><strong>Geri \u00d6deme Haberlerini Takip Edin<\/strong>: Medicare kapsam\u0131yla ilgili olumlu geli\u015fmeler b\u00fcy\u00fck bir kataliz\u00f6r olabilir.<\/li> <\/ol> <p>Ve esprili yorumum: \"CSTL ticareti, bir t\u0131bbi drama izlemek gibi\u2014bolca gerilim, ara s\u0131ra kalp \u00e7arp\u0131nt\u0131s\u0131, ama at\u0131l\u0131m anlar\u0131 her \u015feye de\u011fer k\u0131l\u0131yor!\"<\/p> <h2>\u2705 Ad\u0131m Ad\u0131m: Castle Biosciences (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2> <p>Haz\u0131r m\u0131s\u0131n\u0131z? \u0130\u015fte eylem plan\u0131n\u0131z:<\/p> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Platformunuzu Se\u00e7in<\/td><td>NASDAQ hisselerini sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"CSTL\" Aramas\u0131 Yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td><\/tr> <\/tbody> <\/table> <p>Unutmay\u0131n: Biyoteknoloji yat\u0131r\u0131m\u0131 sab\u0131r gerektirir. Bu h\u0131zl\u0131 zengin olma plan\u0131 de\u011fil\u2014t\u0131bbi inovasyona yap\u0131lan hesapl\u0131 bir bahis.<\/p> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az g\u00f6z korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> - Daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong> - Sadece bir belge ile h\u0131zl\u0131ca KYC s\u00fcre\u00e7lerini tamamlayarak ba\u015flayabilirsiniz<\/li> <li><strong>Esnek Para \u00c7ekme<\/strong> - Kripto paralar ve e-c\u00fczdanlar dahil bir\u00e7ok y\u00f6ntemle karlar\u0131n\u0131za eri\u015fim<\/li> <\/ul> <p>Bu eri\u015filebilirlik, CSTL gibi hisselere karma\u015f\u0131kl\u0131k olmadan yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option\u2019u \u00f6zellikle \u00e7ekici k\u0131l\u0131yor.<\/p> <h2>\ud83c\udfe5 Castle Biosciences 2025\u2019te: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2> <p>Castle Biosciences, doktorlar\u0131n daha iyi tedavi kararlar\u0131 vermesine yard\u0131mc\u0131 olan molek\u00fcler tan\u0131 alan\u0131nda uzmanla\u015fm\u0131\u015f, t\u0131p ve teknolojinin kesi\u015fim noktas\u0131nda yer al\u0131yor. 2007-2008\u2019de kurulan \u015firket, hasta bak\u0131m kararlar\u0131n\u0131 do\u011frudan etkileyen <strong>300.000\u2019den fazla test raporu<\/strong> sundu.<\/p> <p>Amiral gemisi \u00fcr\u00fcn\u00fc DecisionDx-Melanoma, kanser metastaz riskini tahmin etmek i\u00e7in gen ekspresyon profillemesi kullan\u0131yor\u2014doktorlara her vakay\u0131 ne kadar agresif tedavi edecekleri konusunda benzersiz i\u00e7g\u00f6r\u00fcler sa\u011fl\u0131yor. Son FDA at\u0131l\u0131m tasar\u0131s\u0131 ile bu teknoloji t\u0131p d\u00fcnyas\u0131nda kabul g\u00f6rmeye ba\u015flad\u0131.<\/p> <p>\u015eirketin ruh sa\u011fl\u0131\u011f\u0131 tan\u0131lar\u0131 ve yeni dermatolojik durumlara geni\u015flemesi, sadece kanser tan\u0131 \u015firketi olmaktan ziyade kapsaml\u0131 bir hassas t\u0131p platformu olma hedefini g\u00f6steriyor.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Castle Biosciences testleri klinik olarak o kadar de\u011ferli hale geldi ki, baz\u0131 sigorta \u015firketleri art\u0131k bunlar\u0131 standart bak\u0131m olarak kar\u015f\u0131lamay\u0131 d\u00fc\u015f\u00fcn\u00fcyor\u2014bu, sadece finansal metriklerin \u00f6tesinde t\u0131bbi etkilerinin b\u00fcy\u00fck bir onay\u0131d\u0131r.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Castle Biosciences Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla, Castle Biosciences (CSTL) hisseleri <strong>21,35 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor ve hassas t\u0131p devrimine g\u00f6z diken yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir giri\u015f noktas\u0131 sunuyor.<\/p>\n<p><strong>Takviminize not edin: 3 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck f\u0131rsat\u0131n\u0131z. Castle Biosciences, piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketlerine neden olur\u2014hem yukar\u0131 hem de a\u015fa\u011f\u0131 y\u00f6nl\u00fc.<\/p>\n<h3>Kazan\u00e7 Etkisi Analizi: Haberler CSTL Hissesini Nas\u0131l Hareket Ettiriyor<\/h3>\n<p>Bu \u015firketin finansal haberlere nas\u0131l tepki verdi\u011fini g\u00f6stereyim. \u0130\u015fte son kazan\u00e7lardan sonra olanlar:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>19,90 $<\/td>\n<td><strong>%8,2 Art\u0131\u015f<\/strong> (tahminleri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>5 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>22,50 $<\/td>\n<td><strong>%4,0 Art\u0131\u015f<\/strong> (gelir art\u0131\u015f\u0131)<\/td>\n<\/tr>\n<tr>\n<td>\u015eub 2025<\/td>\n<td>Ayl\u0131k Kapan\u0131\u015f<\/td>\n<td>27,05 $<\/td>\n<td><strong>%-0,53 D\u00fc\u015f\u00fc\u015f<\/strong> (stabil d\u00f6nem)<\/td>\n<\/tr>\n<tr>\n<td>Oca 2025<\/td>\n<td>Volatilite Art\u0131\u015f\u0131<\/td>\n<td>23,95 $<\/td>\n<td><strong>%6,08 Art\u0131\u015f<\/strong> (toparlanma)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Desen a\u00e7\u0131k: Castle Biosciences genellikle olumlu kazan\u00e7 s\u00fcrprizlerine iyi tepki veriyor. 4 A\u011fustos raporu beklentileri ezerek %8,2\u2019lik bir s\u0131\u00e7rama yaratt\u0131. Bu volatilite, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem risk hem de f\u0131rsat yarat\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>Castle Biosciences, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131. Hikaye \u015f\u00f6yle geli\u015fti:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 27,05-28,90 $ aras\u0131nda i\u015flem g\u00f6r\u00fcrken, hisse % -0,53 gibi minimal bir hareketle istikrar g\u00f6sterdi. Yat\u0131r\u0131mc\u0131lar temkinli iyimserdi.<\/p>\n<p><strong>Mart-Nisan 2025<\/strong>: Hisse, piyasa \u015firketin b\u00fcy\u00fcme yol haritas\u0131n\u0131 de\u011ferlendirirken yakla\u015f\u0131k 24 $ destek seviyelerini test ederek konsolidasyon a\u015famas\u0131na girdi.<\/p>\n<p><strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek kazan\u00e7lar\u0131 yenilenmi\u015f ilgi uyand\u0131rd\u0131 ve fiyatlar\u0131 23-25 $ aral\u0131\u011f\u0131na ta\u015f\u0131d\u0131; y\u0131ll\u0131k %21 olumlu gelir art\u0131\u015f\u0131 g\u00f6r\u00fcld\u00fc.<\/p>\n<p><strong>Haziran-Temmuz 2025<\/strong>: Atopik dermatit testleri i\u00e7in SciBase i\u015f birli\u011fi duyurusu heyecan yaratt\u0131, ancak geri \u00f6deme endi\u015feleri ge\u00e7ici olarak co\u015fkuyu azaltt\u0131.<\/p>\n<p><strong>A\u011fustos 2025<\/strong>: \u015eu anki 21,35 $ civar\u0131ndaki i\u015flem fiyat\u0131, bir\u00e7ok analistin son bask\u0131lar sonras\u0131 potansiyel bir de\u011fer f\u0131rsat\u0131 olarak g\u00f6rd\u00fc\u011f\u00fc seviyeyi temsil ediyor.<\/p>\n<p>Genel trend? <strong>\u015eubat zirvelerinden %17 d\u00fc\u015f\u00fc\u015f<\/strong>, ancak g\u00fc\u00e7l\u00fc temel performans bunun uzun vadeli bir d\u00fc\u015f\u00fc\u015ften ziyade ge\u00e7ici bir gerileme olabilece\u011fini g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket performans\u0131na dayanarak, gelecekte neler olabilir:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 26-28 $ (y\u00fczde 22-31 art\u0131\u015f) \u2192 <strong>AL<\/strong><br \/> G\u00fc\u00e7l\u00fc 3. ve 4. \u00e7eyrek performans\u0131 bekleniyor, gelir rehberi zaten 310-320 milyon $ olarak y\u00fckseltildi<\/li>\n<li><strong>2026<\/strong>: 32-35 $ (y\u00fczde 50-64 b\u00fcy\u00fcme)<br \/> Yeni dermatolojik testlerin geni\u015flemesi ve potansiyel FDA onaylar\u0131 b\u00fcy\u00fcmeyi tetikliyor<\/li>\n<li><strong>2028<\/strong>: 40-45 $ (y\u00fczde 87-111 de\u011fer art\u0131\u015f\u0131)<br \/> Hassas dermatoloji tan\u0131 pazar\u0131nda liderlik kurulacak<\/li>\n<li><strong>2030<\/strong>: 50 $+ (y\u00fczde 134+ potansiyel)<br \/> Geni\u015fletilmi\u015f test portf\u00f6y\u00fc ile molek\u00fcler tan\u0131 alan\u0131nda hakimiyet<\/li>\n<\/ul>\n<p>Ortalama hedef fiyat\u0131 37,67 $ olan analistlerin oybirli\u011fiyle verdikleri <strong>G\u00fc\u00e7l\u00fc Al tavsiyesi<\/strong>, bu b\u00fcy\u00fcme yolunda \u00f6nemli bir g\u00fcveni g\u00f6steriyor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2>\n<p>Yat\u0131r\u0131m yapmadan \u00f6nce bu potansiyel riskleri anlay\u0131n:<\/p>\n<ul>\n<li><strong>Reg\u00fclasyon Riskleri<\/strong>: FDA onay s\u00fcre\u00e7leri yeni \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir. DecisionDx-SCC i\u00e7in Medicare geri \u00f6deme sorunlar\u0131, politika de\u011fi\u015fikliklerinin marjlar\u0131 nas\u0131l etkileyebilece\u011fini g\u00f6steriyor.<\/li>\n<li><strong>Mali Volatilite<\/strong>: G\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131na ra\u011fmen (-9,47M $ TTM zarar), k\u00e2rl\u0131l\u0131k \u00f6l\u00e7ek b\u00fcy\u00fcmesi sa\u011flanana kadar endi\u015fe kayna\u011f\u0131d\u0131r.<\/li>\n<li><strong>Rekabetin Artmas\u0131<\/strong>: Daha b\u00fcy\u00fck tan\u0131 \u015firketleri, Castle\u2019\u0131n ni\u015f pazarlar\u0131na rakip teknolojilerle girebilir.<\/li>\n<li><strong>\u0130\u00e7erden Sat\u0131\u015flar<\/strong>: Son d\u00f6nemdeki y\u00f6netici hisse sat\u0131\u015flar\u0131, muhtemelen planl\u0131 olsa da, bireysel yat\u0131r\u0131mc\u0131lar aras\u0131nda olumsuz alg\u0131 yaratabilir.<\/li>\n<\/ul>\n<h2>\ud83d\udea6 Olumlu Sinyaller: Neden Analistler \u0130yimser?<\/h2>\n<p>\u0130yi haberler \u015fimdi\u2014ak\u0131ll\u0131 paran\u0131n heyecanlanmas\u0131n\u0131n nedenleri:<\/p>\n<ul>\n<li><strong>Gelir B\u00fcy\u00fcme Motoru<\/strong>: 2025 1. \u00e7eyre\u011finde %21 y\u0131ll\u0131k b\u00fcy\u00fcme ile 88 milyon $ gelir, g\u00fc\u00e7l\u00fc ticari uygulamay\u0131 g\u00f6steriyor.<\/li>\n<li><strong>\u0130novasyon Hatt\u0131<\/strong>: Atopik dermatit testleri i\u00e7in SciBase i\u015f birli\u011fi, ABD\u2019de 24 milyon hastay\u0131 hedefleyen devasa bir adreslenebilir pazar.<\/li>\n<li><strong>Pazar Liderli\u011fi<\/strong>: 2008\u2019den beri 300.000\u2019den fazla test raporu sunulmas\u0131, klinik g\u00fcvenilirlik ve doktor ili\u015fkileri kurdu.<\/li>\n<li><strong>Nakit Pozisyonu<\/strong>: 275,9 milyon $ nakit rezervi, seyrelme olmadan sat\u0131n almalar ve Ar-Ge i\u00e7in finansman sa\u011fl\u0131yor.<\/li>\n<\/ul>\n<h2>\ud83d\udcca \u00d6nemli Haber Analizi: 2025 Geli\u015fmeleri<\/h2>\n<p>Son alt\u0131 ayda her CSTL yat\u0131r\u0131mc\u0131s\u0131n\u0131n anlamas\u0131 gereken kritik geli\u015fmeler:<\/p>\n<ul>\n<li><strong>2. \u00c7eyrek Kazan\u00e7 S\u00fcrprizi (4 A\u011fustos)<\/strong>: Castle, -0,51 $ tahminine kar\u015f\u0131 0,15 $ EPS ile beklentileri ezdi. 86,18 milyon $ gelir tahminleri %20 a\u015ft\u0131. Bu, zorluklara ra\u011fmen operasyonel m\u00fckemmelli\u011fi g\u00f6steriyor.<\/li>\n<li><strong>SciBase \u0130\u015f Birli\u011fi (Haziran 2025)<\/strong>: Atopik dermatit testleri geli\u015ftirmek i\u00e7in bu ortakl\u0131k d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc olabilir. Sadece ABD\u2019de 24 milyon potansiyel hasta ile b\u00fcy\u00fck bir kar\u015f\u0131lanmam\u0131\u015f ihtiyaca hitap ediyor.<\/li>\n<li><strong>FDA At\u0131l\u0131m Tasar\u0131m\u0131<\/strong>: DecisionDx-Melanoma\u2019n\u0131n bu stat\u00fcy\u00fc almas\u0131, teknolojinin potansiyelini do\u011fruluyor ve tam onay yolunu kolayla\u015ft\u0131r\u0131yor.<\/li>\n<li><strong>Geri \u00d6deme Zorluklar\u0131<\/strong>: Medicare politika de\u011fi\u015fiklikleri br\u00fct marj\u0131 %80,7\u2019den %77,3\u2019e d\u00fc\u015f\u00fcrd\u00fc, ancak y\u00f6netim bunu yeniden de\u011ferlendirme talepleriyle aktif olarak ele al\u0131yor.<\/li>\n<\/ul>\n<h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2>\n<p>Analizime dayanarak, \u00f6nerilerim \u015funlar:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5\u2019inden fazlas\u0131n\u0131 ba\u015flang\u0131\u00e7ta CSTL\u2019ye ay\u0131rmay\u0131n\u2014bu y\u00fcksek b\u00fcy\u00fcme ve y\u00fcksek riskli bir yat\u0131r\u0131m.<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferde b\u00fcy\u00fck al\u0131m yerine, \u00f6n\u00fcm\u00fczdeki 2-3 ay i\u00e7inde taksitlerle almay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li>\n<li><strong>3 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: Kazan\u00e7 tarihini i\u015faretleyin ve rapor sonras\u0131 olas\u0131 d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 haz\u0131r olun.<\/li>\n<li><strong>Geri \u00d6deme Haberlerini Takip Edin<\/strong>: Medicare kapsam\u0131yla ilgili olumlu geli\u015fmeler b\u00fcy\u00fck bir kataliz\u00f6r olabilir.<\/li>\n<\/ol>\n<p>Ve esprili yorumum: &#8220;CSTL ticareti, bir t\u0131bbi drama izlemek gibi\u2014bolca gerilim, ara s\u0131ra kalp \u00e7arp\u0131nt\u0131s\u0131, ama at\u0131l\u0131m anlar\u0131 her \u015feye de\u011fer k\u0131l\u0131yor!&#8221;<\/p>\n<h2>\u2705 Ad\u0131m Ad\u0131m: Castle Biosciences (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2>\n<p>Haz\u0131r m\u0131s\u0131n\u0131z? \u0130\u015fte eylem plan\u0131n\u0131z:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Platformunuzu Se\u00e7in<\/td>\n<td>NASDAQ hisselerini sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;CSTL&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Unutmay\u0131n: Biyoteknoloji yat\u0131r\u0131m\u0131 sab\u0131r gerektirir. Bu h\u0131zl\u0131 zengin olma plan\u0131 de\u011fil\u2014t\u0131bbi inovasyona yap\u0131lan hesapl\u0131 bir bahis.<\/p>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az g\u00f6z korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> &#8211; Daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong> &#8211; Sadece bir belge ile h\u0131zl\u0131ca KYC s\u00fcre\u00e7lerini tamamlayarak ba\u015flayabilirsiniz<\/li>\n<li><strong>Esnek Para \u00c7ekme<\/strong> &#8211; Kripto paralar ve e-c\u00fczdanlar dahil bir\u00e7ok y\u00f6ntemle karlar\u0131n\u0131za eri\u015fim<\/li>\n<\/ul>\n<p>Bu eri\u015filebilirlik, CSTL gibi hisselere karma\u015f\u0131kl\u0131k olmadan yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option\u2019u \u00f6zellikle \u00e7ekici k\u0131l\u0131yor.<\/p>\n<h2>\ud83c\udfe5 Castle Biosciences 2025\u2019te: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Castle Biosciences, doktorlar\u0131n daha iyi tedavi kararlar\u0131 vermesine yard\u0131mc\u0131 olan molek\u00fcler tan\u0131 alan\u0131nda uzmanla\u015fm\u0131\u015f, t\u0131p ve teknolojinin kesi\u015fim noktas\u0131nda yer al\u0131yor. 2007-2008\u2019de kurulan \u015firket, hasta bak\u0131m kararlar\u0131n\u0131 do\u011frudan etkileyen <strong>300.000\u2019den fazla test raporu<\/strong> sundu.<\/p>\n<p>Amiral gemisi \u00fcr\u00fcn\u00fc DecisionDx-Melanoma, kanser metastaz riskini tahmin etmek i\u00e7in gen ekspresyon profillemesi kullan\u0131yor\u2014doktorlara her vakay\u0131 ne kadar agresif tedavi edecekleri konusunda benzersiz i\u00e7g\u00f6r\u00fcler sa\u011fl\u0131yor. Son FDA at\u0131l\u0131m tasar\u0131s\u0131 ile bu teknoloji t\u0131p d\u00fcnyas\u0131nda kabul g\u00f6rmeye ba\u015flad\u0131.<\/p>\n<p>\u015eirketin ruh sa\u011fl\u0131\u011f\u0131 tan\u0131lar\u0131 ve yeni dermatolojik durumlara geni\u015flemesi, sadece kanser tan\u0131 \u015firketi olmaktan ziyade kapsaml\u0131 bir hassas t\u0131p platformu olma hedefini g\u00f6steriyor.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Castle Biosciences testleri klinik olarak o kadar de\u011ferli hale geldi ki, baz\u0131 sigorta \u015firketleri art\u0131k bunlar\u0131 standart bak\u0131m olarak kar\u015f\u0131lamay\u0131 d\u00fc\u015f\u00fcn\u00fcyor\u2014bu, sadece finansal metriklerin \u00f6tesinde t\u0131bbi etkilerinin b\u00fcy\u00fck bir onay\u0131d\u0131r.<\/p>\n"},"faq":[{"question":"Castle Biosciences hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Castle Biosciences hisseleri almak i\u00e7in NASDAQ i\u015flem platformlar\u0131ndan birini se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CSTL\" sembol\u00fc ile arama yap\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve i\u015flemi onaylay\u0131n."},{"question":"Castle Biosciences hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon gecikmeleri, mali volatilite, artan rekabet ve i\u00e7erden sat\u0131\u015flar gibi riskler bulunmaktad\u0131r."},{"question":"Castle Biosciences\u2019in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 26-28 $, 2030\u2019da ise 50 $ ve \u00fczeri fiyatlar beklenmektedir, analistler g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcyor."},{"question":"Castle Biosciences\u2019in en \u00f6nemli \u00fcr\u00fcnleri nelerdir?","answer":"DecisionDx-Melanoma ba\u015fta olmak \u00fczere molek\u00fcler tan\u0131 testleri, \u00f6zellikle cilt kanseri ve dermatolojik hastal\u0131klar i\u00e7in geli\u015ftirilmi\u015ftir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama ve esnek para \u00e7ekme se\u00e7enekleri ile yat\u0131r\u0131m yapmay\u0131 kolayla\u015ft\u0131r\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Castle Biosciences hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Castle Biosciences hisseleri almak i\u00e7in NASDAQ i\u015flem platformlar\u0131ndan birini se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CSTL\" sembol\u00fc ile arama yap\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve i\u015flemi onaylay\u0131n."},{"question":"Castle Biosciences hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon gecikmeleri, mali volatilite, artan rekabet ve i\u00e7erden sat\u0131\u015flar gibi riskler bulunmaktad\u0131r."},{"question":"Castle Biosciences\u2019in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 26-28 $, 2030\u2019da ise 50 $ ve \u00fczeri fiyatlar beklenmektedir, analistler g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcyor."},{"question":"Castle Biosciences\u2019in en \u00f6nemli \u00fcr\u00fcnleri nelerdir?","answer":"DecisionDx-Melanoma ba\u015fta olmak \u00fczere molek\u00fcler tan\u0131 testleri, \u00f6zellikle cilt kanseri ve dermatolojik hastal\u0131klar i\u00e7in geli\u015ftirilmi\u015ftir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama ve esnek para \u00e7ekme se\u00e7enekleri ile yat\u0131r\u0131m yapmay\u0131 kolayla\u015ft\u0131r\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T14:06:44+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T14:06:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/\",\"name\":\"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-30T14:06:44+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/","og_locale":"tr_TR","og_type":"article","og_title":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T14:06:44+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T14:06:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/","name":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-30T14:06:44+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-castle-biosciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Castle Biosciences, Inc. (CSTL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Castle Biosciences, Inc. (CSTL) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":360364,"slug":"how-to-buy-castle-biosciences","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Castle Biosciences, Inc. (CSTL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Castle Biosciences, Inc. (CSTL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-castle-biosciences\/"},"pt_AA":{"locale":"pt_AA","id":360366,"slug":"how-to-buy-castle-biosciences","post_title":"Como comprar a\u00e7\u00f5es da Castle Biosciences, Inc. (CSTL) - Investimento em a\u00e7\u00f5es da Castle Biosciences, Inc. (CSTL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-castle-biosciences\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/360362","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=360362"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/360362\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=360362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=360362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=360362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}